Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.

Pan, Edward

Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. [electronic resource] - Journal of neuro-oncology 12 2016 - 571-579 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article

1573-7373

10.1007/s11060-016-2263-1 doi


Adult
Antineoplastic Agents--therapeutic use
Benzazepines--therapeutic use
Bevacizumab--therapeutic use
Brain Neoplasms--drug therapy
Female
Glioma--drug therapy
Humans
Male
Middle Aged
Time Factors